A new study finds anifrolumab (Saphnelo) may reduce harmful inflammation and improve signs of overall immune health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results